Wilm's Tumor
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides (NCT01598454) | Laboratorio Elea Phoenix S.A. | 2011-02-01 |
| RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia (NCT01236586) | National Cancer Institute (NCI) | 2010-10-08 |
| Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients (NCT01169584) | Jennerex Biotherapeutics | 2010-08-01 |
| Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions (NCT00758108) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2008-09-11 |
| A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation (NCT00405327) | University of Michigan Rogel Cancer Center | 2006-06-01 |
| National Wilm's Tumor Study Late Effects (NCT00228696) | Emory University | 2005-09-01 |
Track Wilm's Tumor automatically
Every clearance here is in the API, with alerts when new ones post.